Autocrine IL-8 Contributes to Propionibacterium Acnes-induced Proliferation and Differentiation of HaCaT Cells via AKT/FOXO1/ Autophagy

Abstract

Objective

Proprionibacterium acnes (P. acnes)-induced inflammatory responses, proliferation and differentiation of keratinocytes contribute to the progression of acne vulgaris (AV). P. acnes was found to enhance the production of interleukin-8 (IL-8) by keratinocytes. This study aimed to investigate the role of IL-8 in P. acnes-induced proliferation and differentiation of keratinocytes and the underlying mechanism.

Methods

The P. acnes-stimulated HaCaT cell (a human keratinocyte cell line) model was established. Western blotting and immunofluorescence were performed to detect the expression of the IL-8 receptors C-X-C motif chemokine receptor 1 (CXCR1) and C-X-C motif chemokine receptor 2 (CXCR2) on HaCaT cells. Cell counting kit-8 (CCK-8) assay, 5-ethynyl-20-deoxyuridine (EdU) assay and Western blotting were performed to examine the effects of IL-8/CXCR2 axis on the proliferation and differentiation of HaCaT cells treated with P. acnes, the IL-8 neutralizing antibody, the CXCR2 antagonist (SB225002), or the CXCR1/CXCR2 antagonist (G31P). Western blotting, nuclear and cytoplasmic separation, CCK-8 assay, and EdU assay were employed to determine the downstream pathway of CXCR2 after P. acnes-stimulated HaCaT cells were treated with the CXCR2 antagonist, the protein kinase B (AKT) antagonist (AZD5363), or the constitutively active forkhead box O1 (FOXO1) mutant. Finally, autophagy markers were measured in HaCaT cells following the transfection of the FOXO1 mutant or treatment with the autophagy inhibitor 3-methyladenine (3-MA).

Results

The expression levels of CXCR1 and CXCR2 were significantly increased on the membrane of HaCaT cells following P. acnes stimulation. The IL-8/CXCR2 axis predominantly promoted the proliferation and differentiation of P. acnes-induced HaCaT cells by activating AKT/FOXO1/autophagy signaling. In brief, IL-8 bound to its receptor CXCR2 on the membrane of keratinocytes to activate the AKT/FOXO1 axis. Subsequently, phosphorylated FOXO1 facilitated autophagy to promote the proliferation and differentiation of P. acnes-induced keratinocytes.

Conclusion

This study demonstrated the novel autocrine effect of IL-8 on the proliferation and differentiation of P. acnes-induced keratinocytes, suggesting a potential therapeutic target for AV.

References

[1] Melnik BC. Acne vulgaris: The metabolic syndrome of the pilosebaceous follicle. Clin Dermatol, 2018, 36(1): 29-40

[2] Kodra V, Shehu E, Xhaja A. Self-esteem and mental health in adolescents with acne vulgaris. Eur Neuropsychopharm, 2018, 28: S44-S45

[3] Zaenglein AL. Acne Vulgaris. N Engl J Med, 2018, 379(14): 1343-1352

[4] Shin JH, Kim SS, Seo SR. Pyrrolidine Dithiocarbamate Suppresses Cutibacterium acnes-Induced Skin Inflammation. Int J Mol Sci, 2023, 24(5): 4444

[5] Sahdo B, Sarndahl E, Elgh F, et al.. Propionibacterium acnes activates caspase-1 in human neutrophils. APMIS, 2013, 121(7): 652-663

[6] Zeng R, Xu H, Liu Y, et al.. miR-146a Inhibits Biofilm-Derived Cutibacterium acnes-Induced Inflammatory Reactions in Human Keratinocytes. J Invest Dermatol, 2019, 139(12): 2488-2496

[7] Taylor M, Gonzalez M, Porter R. Pathways to inflammation: acne pathophysiology. Eur J Dermatol, 2011, 21(3): 323-333

[8] Gozali MV, Yi F, Zhang JA, et al.. Photodynamic therapy inhibit fibroblast growth factor-10 induced keratinocyte differentiation and proliferation through ROS in fibroblast growth factor receptor-2b pathway. Sci Rep, 2016, 6: 27402

[9] Mendieta D, De la Cruz-Aguilera DL, Barrera-Villalpando MI, et al.. IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients. J Neuroimmunol, 2016, 290: 22-25

[10] Geng R, Tan X, Wu J, et al.. RNF183 promotes proliferation and metastasis of colorectal cancer cells via activation of NF-kappaB-IL-8 axis. Cell Death Dis, 2017, 8(8): e2994

[11] Delaunay J, Lecomte N, Bourcier S, et al.. Contribution of GM-CSF and IL-8 to the CD44-induced differentiation of acute monoblastic leukemia. Leukemia, 2008, 22(4): 873-876

[12] Grange PA, Raingeaud J, Calvez V, et al.. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways. J Dermatol Sci, 2009, 56(2): 106-112

[13] Zhu T, Fang F, Sun D, et al.. Piceatannol Inhibits P. acnes-Induced Keratinocyte Proliferation and Migration by Downregulating Oxidative Stress and the Inflammatory Response. Inflammation, 2019, 43(1): 347-357

[14] Visciano C, Liotti F, Prevete N, et al.. Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway. Oncogene, 2015, 34(40): 5175-5186

[15] Jackson JG, Kreisberg JI, Koterba AP, et al.. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells. Oncogene, 2000, 19(40): 4574-4581

[16] Southgate RJ, Bruce CR, Carey AL, et al.. PGC-1alpha gene expression is downregulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle. FASEB J, 2005, 19(14): 2072-2074

[17] Zhao Y, Yang J, Liao W, et al.. Cytosolic FoxO1 is essential for the induction of autophagy and tumor suppressor activity. Nat Cell Biol, 2010, 12(7): 665-675

[18] Kim KM, Park SJ, Jung SH, et al.. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1. J Bone Miner Res, 2012, 27(8): 1669-1679

[19] Daitoku H, Hatta M, Matsuzaki H, et al.. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci U S A, 2004, 101(27): 10042-10047

[20] Wu H, Cao Y, Weng D, et al.. Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms. Cancer Lett, 2008, 271(2): 260-271

[21] Eom SH, Lee EH, Park K, et al.. Eckol from Eisenia bicyclis Inhibits Inflammation Through the Akt/NF-kappa B Signaling in Propionibacterium acnes-Induced Human Keratinocyte Hacat Cells. J Food Biochem, 2017, 41(2): 12312

[22] Mirdamadi Y, Thielitz A, Wiede A, et al.. Insulin and insulinlike growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitro. Mol Cell Endocrinol, 2015, 415: 32-44

[23] Cong TX, Hao D, Wen X, et al.. From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res, 2019, 311(5): 337-349

[24] Reynolds RV, Yeung H, Cheng CE, et al.. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol, 2024, 90(5): 1006.e1-1006.e30

[25] Agamia NF, Hussein OM, Abdelmaksoud RE, et al.. Effect of oral isotretinoin on the nucleo-cytoplasmic distribution of FoxO1 and FoxO3 proteins in sebaceous glands of patients with acne vulgaris. Exp Dermatol, 2018, 27(12): 1344-1351

[26] Wang S, Xia P, Huang G, et al.. FoxO1-mediated autophagy is required for NK cell development and innate immunity. Nat Commun, 2016, 7: 11023

[27] Xie X, Dai H, Zhuang B, et al.. Exogenous hydrogen sulfide promotes cell proliferation and differentiation by modulating autophagy in human keratinocytes. Biochem Biophys Res Commun, 2016, 472(3): 437-443

[28] Boyanova L. Cutibacterium acnes (formerly Propionibacterium acnes): friend or foe?. Future Microbiol, 2023, 18: 235-244

[29] Dessinioti C, Katsambas A. Antibiotics and Antimicrobial Resistance in Acne: Epidemiological Trends and Clinical Practice Considerations. Yale J Biol Med, 2022, 95(4): 429-443

[30] Hwang HJ, Kim JE, Lee KW. Sulforaphene Attenuates Cutibacterium acnes-Induced Inflammation. J Microbiol Biotechnol, 2022, 32(11): 1390-1395

[31] Cao J, Xu M, Zhu L, et al.. Viaminate Inhibits Propionibacterium Acnes-induced Abnormal Proliferation and Keratinization of HaCat Cells by Regulating the S100A8/S100A9-MAPK Cascade. Curr Drug Targets, 2023, 24(13): 1055-1065

[32] Nguyen AT, Kim KY. Inhibition of Proinflammatory Cytokines in Cutibacterium acnes-Induced Inflammation in HaCaT Cells by Using Buddleja davidii Aqueous Extract. Int J Inflam, 2020, 2020: 8063289

[33] Paquet P, Ribbens C, Pierard GE. Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis. Clin Exp Dermatol, 2007, 32(6): 728-732

[34] Mabuchi T, Chang TW, Quinter S, et al.. Chemokine receptors in the pathogenesis and therapy of psoriasis. J Dermatol Sci, 2012, 65(1): 4-11

[35] Numerof RP, Asadullah K. Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis. BioDrugs, 2006, 20(2): 93-103

[36] Zhang E, Feng X, Liu F, et al.. Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1alpha, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells. PLoS One, 2014, 9(7): e103440

[37] Liu HT, Huang P, Ma P, et al.. Chitosan oligosaccharides suppress LPS-induced IL-8 expression in human umbilical vein endothelial cells through blockade of p38 and Akt protein kinases. Acta Pharmacol Sin, 2011, 32(4): 478-486

[38] Westergaard M, Henningsen J, Svendsen ML, et al.. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. J Invest Dermatol, 2001, 116(5): 702-712

[39] Grygiel-Górniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications–a review. Nutr J, 2014, 13: 17

[40] Zhang C, He Y, Okutsu M, et al.. Autophagy is involved in adipogenic differentiation by repressesing proteasome-dependent PPARgamma2 degradation. Am J Physiol Endocrinol Metab, 2013, 305(4): E530-E539

[41] Jiao Y, Liang X, Hou J, et al.. Adenovirus type 36 regulates adipose stem cell differentiation and glucolipid metabolism through the PI3K/Akt/FoxO1/PPARγ signaling pathway. Lipids Health Dis, 2019, 18(1): 70

[42] Alfaro C, Sanmamed MF, Rodriguez-Ruiz ME, et al.. Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat Rev, 2017, 60: 24-31

[43] Bilusic M, Heery CR, Collins JM, et al.. Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors. J Immunother Cancer, 2019, 7(1): 240

[44] Rennard SI, Dale DC, Donohue JF, et al.. CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 2015, 191(9): 1001-1011

[45] Shirley M. Capivasertib: First Approval. Drugs, 2024, 84(3): 337-346

[46] Jeon HH, Yu Q, Witek L, et al.. Clinical application of a FOXO1 inhibitor improves connective tissue healing in a diabetic minipig model. Am J Transl Res, 2021, 13(2): 781-791